Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Glytech designs novel cancer immunotherapeutic

April 30, 2013

Listeria-based prostate cancer vaccines developed at Aduro BioTech

April 30, 2013

European CHMP recommends conditional approval of Erivedge for BCC

April 29, 2013

Lambrolizumab designated as breakthrough therapy by the FDA

April 26, 2013

BMS-986015 shows efficacy in a novel animal model of lymphoma

April 26, 2013

Dosing begins in phase I/II anal cancer study of ADXS-HPV

April 24, 2013

New prostate cancer vaccine is safe in patients

April 24, 2013

Roche develops interleukin-2 variant for cancer immunotherapy

April 23, 2013

Phase II study of BI-505 in multiple myeloma begins

April 22, 2013

NKTR-214 is significantly more efficacious in vivo compared to aldesleukin

April 22, 2013

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...